Daniel Abdun-Nabi, CEO at Emergent BioSolutions Inc. (EBS), bought 800 shares at $12.07 ($10K) on 2013-05-31, disclosed to the SEC on 2013-06-04.
Open-market purchase of $10k EBS by CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| EBS | SELL | 2018-09-18 | $1.9M | — | Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |